Patents by Inventor Helene Rouquette

Helene Rouquette has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230159654
    Abstract: Novels antibodies, preferably monoclonal antibodies, or antigen-binding fragments thereof, said antibody or fragment thereof specifically binding to CD5. These antibodies may be used as a medicament, especially in the treatment of diseases in immunomodulation, inflammation, virology, infectiology, autoimmunity and oncology domains. Immune cells and/or cancer cells targeted by the invention are expressing CD5 antigen. These antibodies may be in particular chimeric or humanized. The invention also relates to pharmaceutical compositions, such as immunomodulator, anti-cancerous and anti-infectious compositions, containing such an antibody or antigen-binding fragment and methods of use of these, either for laboratory work, in drug manufacturing, such as in cell therapy cells production, or for medical treatment.
    Type: Application
    Filed: November 24, 2021
    Publication date: May 25, 2023
    Inventors: Claudine VERMOT-DESROCHES, Hélène ROUQUETTE, Benoît MILCENT
  • Patent number: 6630114
    Abstract: The invention relates to new calixarenes according to the formula: wherein R1 and R2, which may be identical or different, are alkyl, alkoxy or aryl groups, and n is an integer equal to 2, 3 or 4. Said calixarenes may be used to extract actinides and lanthanides from aqueous solutions.
    Type: Grant
    Filed: July 10, 2001
    Date of Patent: October 7, 2003
    Assignee: Commissariat a l'Energie Atomique
    Inventors: Jean-François Dozol, Hélène Rouquette, Alejandro Garcia Carrera, Laetitia Delmau, Volker Böhmer, Alexander Shivanyuk, Christian Muzigmann
  • Patent number: 5926687
    Abstract: The invention relates to crown calix.vertline.4.vertline.arenes, their preparation process and their use for the selective extraction of cesium and actinides. These crown calixl4larenes comply with the formula: ##STR1## in which R.sub.1 represents a group of formula X(C.sub.2 H.sub.4 X).sub.m and X(C.sub.2 H.sub.4 X).sub.n YX(C.sub.2 H.sub.4 X).sub.n with X=O or N(R.sub.4), m=3, 4, 5 or 6, Y=cycloalkylene or arylene and n=1, 2 or 3. These crown.vertline.4.vertline.arenes, whose benzene nuclei are optionally substituted by alkyl groups, can be used as extractants, e.g. in liquid membrane form, for separating cesium from acid solutions containing sodium in a large quantity compared with the cesium quantity, e.g. irradiated fuel reprocessing plant effluents.
    Type: Grant
    Filed: October 4, 1995
    Date of Patent: July 20, 1999
    Assignee: Commissariat a l'Energie Atomique
    Inventors: Jean-Fran.cedilla.ois Dozol, Helene Rouquette, Rocco Ungaro, Alessandro Casnati
  • Patent number: 5866087
    Abstract: The invention relates to novel calixarenes of formula: ##STR1## in which m is equal to 0 or 1, n is an integer from 2 to 8, with 4.ltoreq.n(m+1).ltoreq.8,R.sup.1 and R.sup.2, which can be the same or different, are alkyl or O-nitrophenoxyalkyl groups andR.sup.3 and R.sup.4, which can be the same or different, are alkyl or aryl groups.The calixarenes can be used for extracting actinides and lanthanides from aqueous solutions from spent fuel reprocessing.
    Type: Grant
    Filed: October 14, 1997
    Date of Patent: February 2, 1999
    Assignee: Commissariat a l'Energie Atomique
    Inventors: Jean-Fran.cedilla.ois Dozol, Helene Rouquette, Volker Bohmer, Cordula Gruttner, Ralf A. Jakobi, Dagmar Kraft, Walter Vogt